Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 71
Filtrar
2.
J Am Board Fam Med ; 37(1): 150-152, 2024 Mar 11.
Artículo en Inglés | MEDLINE | ID: mdl-38448234

RESUMEN

In hospitalized patients with type 2 diabetes (T2DM), a less aggressive supplemental insulin regimen is noninferior to a standard, more aggressive, supplemental regimen.


Asunto(s)
Diabetes Mellitus Tipo 2 , Insulina , Humanos , Insulina/uso terapéutico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Glucemia , Esquema de Medicación , Pacientes Internos , Hipoglucemiantes/uso terapéutico , Hospitalización
3.
J Fam Pract ; 72(7): E23-E25, 2023 09.
Artículo en Inglés | MEDLINE | ID: mdl-37729142

RESUMEN

While treatment with metformin or lifestyle modification reduces risk for T2D in patients with prediabetes, neither intervention ultimately offers a mortality benefit.


Asunto(s)
Metformina , Estado Prediabético , Humanos , Estado Prediabético/diagnóstico , Estado Prediabético/terapia , Terapia Conductista , Estilo de Vida , Metformina/uso terapéutico
4.
J Fam Pract ; 72(7): 320-321, 2023 09.
Artículo en Inglés | MEDLINE | ID: mdl-37729143

RESUMEN

YES. Low-dose naltrexone is as effective as amitriptyline in the treatment of painful diabetic neuropathy and has a superior safety profile (strength of recommendation [SOR], B; single randomized controlled trial [RCT]). Low-dose naltrexone significantly reduced pain by 32% in inflammatory conditions and 44% in neuropathic conditions (SOR, B; single retrospective cohort study). Doses as low as 5.4 mg were found to reduce pain in 95% of patients with fibromyalgia (SOR, B; single prospective dose-response study).


Asunto(s)
Fibromialgia , Naltrexona , Humanos , Naltrexona/uso terapéutico , Manejo del Dolor , Amitriptilina , Fibromialgia/tratamiento farmacológico , Dolor
6.
J Fam Pract ; 72(4): E10-E11, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-37224546

RESUMEN

NO. Hormone replacement therapy (HRT) does not prevent cognitive decline in postmenopausal women-and in fact, it may slightly increase risk (strength of recommendation, A; systematic review, meta-analysis of randomized controlled trials [RCTs], and individual RCT).


Asunto(s)
Disfunción Cognitiva , Posmenopausia , Femenino , Humanos , Disfunción Cognitiva/prevención & control , Terapia de Reemplazo de Hormonas , Ensayos Clínicos Controlados Aleatorios como Asunto
8.
J Fam Pract ; 72(1): E10-E12, 2023 01.
Artículo en Inglés | MEDLINE | ID: mdl-36749976

RESUMEN

Yes, patients should do just that. In a randomized clinical trial, symptom duration was reduced when teens and young adults observed a certain screen-time hiatus.


Asunto(s)
Traumatismos en Atletas , Conmoción Encefálica , Síndrome Posconmocional , Adulto Joven , Adolescente , Humanos , Síndrome Posconmocional/diagnóstico , Traumatismos en Atletas/diagnóstico , Factores de Tiempo , Electrónica
10.
Prim Care ; 49(4): 609-619, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36357065

RESUMEN

During the COVID-19 pandemic, providers and patients explored the use of telehealth on a wide and rapid scale. Reflecting on how prenatal providers and pregnant patients used telehealth during the pandemic and afterward, we review existing and new lessons learned from the pandemic. This article summarizes international and national guidelines on prenatal care, presents practice examples on how telehealth and remote patient monitoring were used during the COVID-19 pandemic, and offers lessons learned and suggestions for future care.


Asunto(s)
COVID-19 , Telemedicina , Embarazo , Femenino , Humanos , Pandemias , Atención Prenatal , SARS-CoV-2
11.
J Fam Pract ; 71(6): E16-E17, 2022 07.
Artículo en Inglés | MEDLINE | ID: mdl-35994761

RESUMEN

YES. Infants respond to behavioral interventions, although objective data are limited. Behavioral interventions include establishing regular daytime and sleep routines for the infant, reducing environmental noises or distractions, and allowing for self-soothing at bedtime (strength of recommendation: B, based on multiple randomized and nonrandomized studies).


Asunto(s)
Terapia Conductista , Sueño , Niño , Humanos , Lactante
17.
18.
Am Fam Physician ; 104(2): 204-205, 2021 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-34383438
20.
J Fam Pract ; 70(4): E5-E6, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-34339367

RESUMEN

NO. Insulin glargine may lead to less patient-reported, symptomatic, and nocturnal hypoglycemia, although overall, there may not be a difference in the risk for severe hypoglycemia orhypoglycemiarelated emergency department (ED) visits and hospitalizations (strength of recommendation [SOR]: B, systematic review of randomized controlled trials [RCTs], individual RCTs, and observational study).


Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Hipoglucemia/inducido químicamente , Insulina Glargina/efectos adversos , Insulina Glargina/uso terapéutico , Insulina Isófana/efectos adversos , Insulina Isófana/uso terapéutico , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA